These 3 ASX shares are in the buy zone right now

What does Bell Potter think is so hot about these three shares?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • These three ASX shares may be buys, Bell Potter believes 
  • The companies range from a retail share with well-known footwear brands to a gold producer and drug developer 
  • All of these shares have charged higher in the last year 

A market analyst has outlined why three ASX shares are a buy in the eyes of the team at Bell Potter.

The Neuren Pharmaceuticals Ltd (ASX: NEU), Gold Road Resources Ltd (ASX: GOR) and Accent Group Ltd (ASX1) share prices could all have an upside, according to analysts.

Let's take a look at these three ASX shares in more detail.

Three colleagues stare at a computer screen with serious looks on their faces.

Image source: Getty Images

Neuren

Neuren Pharmaceuticals has recently been lifted from hold to speculative buy from the perspective of Bell Potter.

The company is working on drugs that can treat neurological disorders including Rett Syndrome.

Commenting at an ASX investor day in Brisbane, Bell Direct market analyst Grady Wulff said Neuren is trading at all-time highs at the moment but said that "this is only the beginning". She added:

Neuren is now a buy due to Food and Drug Administration (FDA) recently approving Neuren's US partner, Acadia Pharmaceuticals' drug Trofinetide for the treatment of Rett Sydrome in Adults and Children aged 2+.

The Neuren share price has exploded 250% in the last year but is down 0.15% in Tuesday's trade.

Accent Group

ASX share Accent Group is another share that is rated as a buy, the team at Bell Potter believes. NSW Back to School vouchers have provided the company with a massive boost, according to analysts.

The retail company is "running at a strong pace" and has strong exposure to young customers in a "tougher spending environment".

Accent owns more than 800 stores with 34 brands and 35 online platforms. These brands include Vans, The Athlete's Foot and Dr Martens.

Bell Direct's Wulff said although retail spend is "expected to decline, clothing and footwear is rising".

Commenting on Accent, Wulff noted:

Bell Potter estimates the $193m retail spending benefit from NSW Back to School vouchers.

Bell Potter believes fresh stock through seasonal periods in 2H23 and favourable trends emerging in casual/trendy & comfortable footwear have benefited footwear sales in Australia.

Gold Road Resources

ASX gold producer Gold Road Resources may also be in the buy zone, Bell Potter believes.

Gold Road Resources shares have risen nearly 31% in the last year. The company's share price is up nearly 1% on Tuesday.

The company is exploring gold projects in Western Australia, South Australia and Queensland. This includes a 50% stake in the Gruyere gold mine in Western Australia's goldfields region.

Commenting on Gold Road, Bell Direct's Wulff said:

GOR is debt free, unhedged, and generates strong cash flows for growth.

Motley Fool contributor Monica O'Shea has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Accent Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A happy person clenching fists in celebration sitting at computer.
Broker Notes

Morgans says hold BHP shares and buy this ASX 200 stock      

Let's see what the broker is saying about these stocks this week.

Read more »

An ASX 200 market analyst holds his hand to his chin and looks closely at his computer screens watching share price movements
Broker Notes

3 ASX 200 shares just upgraded to strong buy — here's what the brokers are saying

Do any of these ASX 200 stocks appeal to you?

Read more »

Person pressing the buy button on a smartphone.
Broker Notes

3 reasons to buy Pro Medicus shares today

A leading analyst believes Pro Medicus shares are now trading at a significant discount.

Read more »

Two men look excited on the trading floor as they hold telephones to their ears and one points upwards.
Broker Notes

Buy, hold, sell: Sigma Healthcare, Macquarie, Santos shares

Brokers reveal their latest ratings and reviews on 3 ASX 200 stocks.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

Buy, hold, sell: Macquarie, Boss Energy, CBA shares

The market looks set to endure a sixth consecutive day in the red.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

Guess which ASX 200 share could rise 90% according to Bell Potter

Let's see what the broker is saying about this stock this week.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

These ASX 200 shares could rise 25% to 70%

Morgans expects big returns from these top stocks.

Read more »

ASX 200 shares broker downgrade origami paper fortune teller with buy hold sell and dollar sign options
Broker Notes

Down 42% in a year, are Boss Energy shares now a bargain buy?

A leading analyst provides his outlook for Boss Energy’s beaten down shares.

Read more »